Plus therapeutics to host virtual kol event on new phase 2 respect-gbm data in recurrent glioblastoma presented at the society for neurooncology (sno) conference on monday, november 20, 2023

Austin, texas, nov. 15, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced it will host a virtual kol event on monday, november 20, 2023 at 10:00 am et to discuss new phase 2 respect-gbm data in recurrent glioblastoma presented at the society for neurooncology (sno) conference. to register, click here.
PSTV Ratings Summary
PSTV Quant Ranking